Imidazo[2,1-b][1,3,4]thiadiazol-2-yl]-1H-pyrrolo[2,3-b]pyridines as Inhibitors of Staphylococcus aureus Biofilm Formation
Antibiotics · 12.06.2026 · 15 (6) · 598
DOI: 10.3390/antibiotics15060598 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antibiotics, online erschienen am 12.06.2026. Verfasst von Domenico Schillaci und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological, Chemical, and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Via Archirafi 32, 90123 Palermo, …. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Recovery and Resilience Plan, European Union—NextGenerationEU, Italian Ministry of University and Research.
Abstract (Originalsprache)
Background/Objectives: Biofilm-related infections represent a major concern in clinical practice because of their poor responsiveness to standard antimicrobial treatments. Over the past decade, many efforts have been made to identify new compounds capable of inhibiting this particularly resistant form of bacterial life. Although several compounds have shown interesting anti-biofilm properties, none have reached the clinic.
Methods
In the present work, we describe the synthesis and biological assessment as anti-biofilm agents, of a novel library of twenty-one imidazo[2,1-b][1,3,4]thiadiazol-2-yl]-1H-pyrrolo[2,3-b]pyridines.
Results
The newly synthesized compounds were in vitro evaluated for their ability to prevent biofilm formation and to eradicate established biofilms in Staphylococcus aureus ATCC 25923 and Pseudomonas aeruginosa ATCC 15442. Additionally, the most potent compounds, 9g and 9u, were in vivo assayed for their safety profile and the anti-infective effect in a Galleria mellonella model.
Conclusions
Derivatives 9g, 9i, 9n, 9q and 9u proved to be potent inhibitors of S. aureus biofilm showing BIC50 values lower than 15 µg/mL. Noteworthy, the in vivo results revealed the promising protective properties of compound 9u in the early stage of staphylococcal infection.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biological, Chemical, and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Via Archirafi 32, 90123 Palermo, Italy.
- Department of Earth and Marine Sciences (DiSTeM), University of Palermo, Viale delle Scienze Ed. 16, 90128 Palermo, Italy.
- Department of Agricultural, Food and Forest Sciences (SAAF), University of Palermo, Viale delle Scienze 13, 90128 Palermo, Italy.
- Department of Pharmacy, University of Salerno, Via G. Paolo II 132, Fisciano, 84084 Salerno, Italy.
ORCID-Profile: Domenico Schillaci, Federica Parisi, Valentina Catania, Barbara Manachini, Serena Indelicato, Tania Ciaglia, Stella Cascioferro
Förderung
- National Recovery and Resilience Plan
- European Union—NextGenerationEU
- Italian Ministry of University and Research
Zitieren
APA
Schillaci, D., Plescia, F., Scianò, F., Parisi, F., Catania, V., Manachini, B., Indelicato, S., Ciaglia, T., Di Dio, A., & Cascioferro, S. (2026). Imidazo[2,1-b][1,3,4]thiadiazol-2-yl]-1H-pyrrolo[2,3-b]pyridines as Inhibitors of Staphylococcus aureus Biofilm Formation. Antibiotics, 15(6), 598. https://doi.org/10.3390/antibiotics15060598
Vancouver
Schillaci D, Plescia F, Scianò F, Parisi F, Catania V, Manachini B, et al. Imidazo[2,1-b][1,3,4]thiadiazol-2-yl]-1H-pyrrolo[2,3-b]pyridines as Inhibitors of Staphylococcus aureus Biofilm Formation. Antibiotics. 2026;15(6):598. doi:10.3390/antibiotics15060598
BibTeX
@article{Schillaci2026,
author = {Schillaci, Domenico and Plescia, Fabiana and Scianò, Fabio and Parisi, Federica and Catania, Valentina and Manachini, Barbara and Indelicato, Serena and Ciaglia, Tania and Di Dio, Anna and Cascioferro, Stella},
title = {Imidazo[2,1-b][1,3,4]thiadiazol-2-yl]-1H-pyrrolo[2,3-b]pyridines as Inhibitors of Staphylococcus aureus Biofilm Formation},
journal = {Antibiotics},
year = {2026},
volume = {15},
number = {6},
pages = {598},
doi = {10.3390/antibiotics15060598}
}
EUVIMED